21 Apr 2025 by admin in UncategorizedComments Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
17 Apr 2025 by admin in UncategorizedComments Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer
17 Apr 2025 by admin in UncategorizedComments Adicet Bio Appoints Michael Grissinger to the Board of Directors
07 Apr 2025 by admin in UncategorizedComments Zenas BioPharma Apoints Haley Laken, Ph.D., as Chief Scientific Oficer April 7, 2025
07 Apr 2025 by admin in UncategorizedComments Sail Biomedicines Appoints Laura Sepp-Lorenzino, Ph.D., to Its Board of Directors
